Literature DB >> 32388718

Heavy and light chain (AHL)-type cardiac amyloidosis: first histopathologic-proven case illustrating involvement of the heart.

Miroslav Sekulic1, Simona Pichler Sekulic2, Astrid Weins3.   

Abstract

Cardiac amyloidosis is most commonly comprised of either a monoclonal immunoglobulin or transthyretin; however, in practice, detailing of the former beyond light chain restriction is not typically performed. We present briefly the case of an 80-year-old man with concern for cardiac amyloidosis and a subsequent endomyocardial biopsy revealing significant deposition of amorphous Congo red-positive material. By immunofluorescence microscopy, the amyloidogenic material showed positive expression for IgG heavy chain and kappa light chain, with negative staining for IgM and IgA heavy chains and lambda light chain supporting a diagnosis of heavy and light chain (AHL)-type amyloidosis. Immunofluorescence staining for the IgG heavy chain subclasses supported and further classified the patient's AHL-type cardiac amyloidosis as being IgG4/kappa restricted. The presented case is the first to illustrate AHL-type cardiac amyloidosis via sampling of heart tissue.

Entities:  

Keywords:  AHL-type amyloidosis; Cardiac amyloidosis; IgG heavy chain subclasses; Immunofluorescence microscopy

Mesh:

Substances:

Year:  2020        PMID: 32388718     DOI: 10.1007/s00428-020-02837-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  14 in total

1.  Heavy and Light chain amyloidosois presenting as complete heart block: A rare presentation of a rare disease.

Authors:  P S Priyamvada; S Morkhandikar; B H Srinivas; S Parameswaran
Journal:  Indian J Nephrol       Date:  2015 Mar-Apr

2.  Cardiac amyloidosis.

Authors:  C Cristina Quarta; Jenna L Kruger; Rodney H Falk
Journal:  Circulation       Date:  2012-09-18       Impact factor: 29.690

3.  Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines.

Authors:  Jean D Sipe; Merrill D Benson; Joel N Buxbaum; Shu-Ichi Ikeda; Giampaolo Merlini; Maria J M Saraiva; Per Westermark
Journal:  Amyloid       Date:  2016-11-24       Impact factor: 7.141

Review 4.  Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade.

Authors:  Fabrizio Chiti; Christopher M Dobson
Journal:  Annu Rev Biochem       Date:  2017-05-12       Impact factor: 23.643

Review 5.  Apolipoproteins and amyloid fibril formation in atherosclerosis.

Authors:  Chai Lean Teoh; Michael D W Griffin; Geoffrey J Howlett
Journal:  Protein Cell       Date:  2011-03-12       Impact factor: 14.870

6.  Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases.

Authors:  Samar M Said; Sanjeev Sethi; Anthony M Valeri; Nelson Leung; Lynn D Cornell; Mary E Fidler; Loren Herrera Hernandez; Julie A Vrana; Jason D Theis; Patrick S Quint; Ahmet Dogan; Samih H Nasr
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-23       Impact factor: 8.237

7.  Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases.

Authors:  Brandon T Larsen; Oana M Mereuta; Surendra Dasari; Ahmed U Fayyaz; Jason D Theis; Julie A Vrana; Martha Grogan; Ahmet Dogan; Angela Dispenzieri; William D Edwards; Paul J Kurtin; Joseph J Maleszewski
Journal:  Histopathology       Date:  2015-09-28       Impact factor: 5.087

Review 8.  Cardiac amyloidosis: pathology, nomenclature, and typing.

Authors:  Joseph J Maleszewski
Journal:  Cardiovasc Pathol       Date:  2015-08-01       Impact factor: 2.185

9.  The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosis.

Authors:  Samih H Nasr; Samar M Said; Anthony M Valeri; Sanjeev Sethi; Mary E Fidler; Lynn D Cornell; Morie A Gertz; Angela Dispenzieri; Francis K Buadi; Julie A Vrana; Jason D Theis; Ahmet Dogan; Nelson Leung
Journal:  Kidney Int       Date:  2013-01-09       Impact factor: 10.612

10.  Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers.

Authors:  Panagiota Kyriakou; Dimitrios Mouselimis; Anastasios Tsarouchas; Angelos Rigopoulos; Constantinos Bakogiannis; Michel Noutsias; Vasileios Vassilikos
Journal:  BMC Cardiovasc Disord       Date:  2018-12-04       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.